Snell Todd M 4
4 · NxStage Medical, Inc. · Filed Dec 11, 2012
Insider Transaction Report
Form 4
Snell Todd M
SVP, QA, Reg.&Clinical Affairs
Transactions
- Disposition to Issuer
Common Stock
2012-12-10$11.04/sh−427$4,714→ 7,330 total
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 14, 2012.